This short phase IIa IMODALS trial, as a prelude to the phase IIb/III MIROCALS trial, showed that low-dose IL-2 (aldesleukin) produces a robust upregulation of the peripheral T reg cell count and a lowering of at least one inflammatory mediator (MCP-1/CCL2)
doi: 10.1001/jama.2022.0078 39 Chang-ChenKJMullurRBernal-MizrachiE
Diabetes The Greek physician Aretaeus, a pupil of Hippocrates used in the 1st Century anno domini for the first time, the term diabetes
Interest in this next-generation compound has surged thanks to its unique triple-agonist mechanism and impressive clinical trial results
The pharmacokinetic data highlight the objective reduction in acetaldehyde levels, which is a more reliable indicator than subjective survey results
As you lose visceral fat and improve body composition, we can use treatments like Sculptra for collagen stimulation, RF Microneedling for skin tightening, or facial balancing to address volume changes in the face that often accompany perimenopause
